Is it appropriate to give scheduled hydralazine with a blood pressure reading of 139/57?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydralazine Should Not Be Given for Blood Pressure of 139/57

Scheduled hydralazine should not be administered with a blood pressure reading of 139/57 as this blood pressure is not elevated and hydralazine could cause harmful hypotension. 1

Assessment of Blood Pressure Reading

  • The blood pressure reading of 139/57 mmHg does not meet criteria for hypertension according to current guidelines, as it is below the threshold of 140/90 mmHg 1
  • The diastolic reading of 57 mmHg is actually low and indicates potential risk for hypotension if blood pressure is further reduced 1
  • This blood pressure does not qualify as a hypertensive urgency (which requires diastolic BP >120 mmHg) or hypertensive emergency (which requires evidence of acute target organ damage) 2

Risks of Administering Hydralazine at This Blood Pressure

  • Hydralazine is a direct vasodilator that can cause significant blood pressure reduction, with effects beginning within 10-30 minutes and lasting 2-4 hours 1
  • Administration at this blood pressure level could lead to symptomatic hypotension, which was the most common adverse event reported in studies of inappropriate hydralazine use 3
  • Hydralazine has unpredictable response and prolonged duration of action, making it unsuitable for use in non-urgent situations, especially with borderline or normal blood pressure 1

Appropriate Use of Hydralazine

  • Hydralazine is indicated for:

    • Hypertensive emergencies when administered intravenously (initial 10 mg via slow IV infusion) 1
    • As a step 5 agent in resistant hypertension management (25 mg three times daily, titrated upward) 1
    • In combination with isosorbide dinitrate for heart failure with reduced ejection fraction 1
  • Hydralazine is not recommended as a first-line agent for acute treatment in most patients due to:

    • Unpredictability of response 1
    • Prolonged duration of action 1
    • Risk of reflex tachycardia 1, 4

Evidence Against "As-Needed" Hydralazine Use

  • A retrospective study found that 36% of PRN (as-needed) antihypertensive administrations were given for SBP <180 mmHg and DBP <110 mmHg, which is below the threshold for acute severe hypertension 5
  • Another study found that intravenous hydralazine is commonly prescribed for non-urgent cases of hypertension in hospitalized patients, with 17% of patients experiencing adverse events, most commonly hypotension 3
  • Changes in blood pressure after hydralazine administration are highly variable and related to baseline blood pressure values, making outcomes unpredictable 3, 6

Recommended Approach

  • For a blood pressure of 139/57 mmHg:

    • Withhold scheduled hydralazine as this could worsen the already low diastolic pressure 1, 3
    • Monitor blood pressure for trends rather than treating a single reading 1
    • If the patient is on scheduled hydralazine for another indication (such as heart failure), consult with the prescribing physician about temporarily holding the dose 1
    • Consider evaluation for causes of low diastolic pressure if this is a persistent finding 1
  • For patients with true hypertension requiring treatment:

    • Follow a stepwise approach to hypertension management as outlined in guidelines 1
    • Reserve hydralazine for specific indications such as resistant hypertension or hypertensive emergencies 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hypertensive urgencies and emergencies.

Journal of clinical pharmacology, 1995

Research

Hydralazine for essential hypertension.

The Cochrane database of systematic reviews, 2011

Research

Duration of hydralazine action in hypertension.

Clinical pharmacology and therapeutics, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.